Galdu-irabazien kontua
NOVABAY PHARMACEUTICALS, INC.
SDEV
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
- | - | - | - | - | - | - | - | 18.23 | 11.90 | 4.38 | 1.05 | 3.48 | 6.95 | 11.02 |
|
Diru-sarreren kostua
|
- | 3.30 | 6.83 | 6.62 | 2.78 | 3.97 | 1.74 | 1.50 | - | - | - | - | - | - | - |
|
Irabazi gordina
|
- | 6.48 | 7.90 | 7.78 | 5.65 | 5.96 | 4.86 | 11.01 | 15.45 | 9.43 | 3.12 | 0.20 | 0.06 | 6.95 | 11.02 |
|
Ustiapen-gastuak
|
8.44 | 12.32 | 15.49 | 22.20 | 14.51 | 12.39 | 14.26 | 18.88 | 22.76 | 20.42 | 24.13 | 17.45 | 18.80 | 15.26 | 15.34 |
|
Ikerketa eta garapena
|
- | 0.04 | 0.07 | 0.17 | 0.04 | 0.29 | 0.18 | 0.26 | 0.41 | 1.37 | 6.05 | 9.51 | 12.46 | 9.28 | 9.91 |
|
Salmentak, orokorrak eta administratiboak
|
7.59 | 7.38 | 6.50 | 7.80 | 7.24 | 6.17 | 8.77 | 12.79 | 13.71 | 11.81 | 18.09 | 7.94 | 6.34 | 5.98 | 5.43 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-8.44 | -5.84 | -7.60 | -14.42 | -8.86 | -6.43 | -9.40 | -7.87 | -7.31 | -10.98 | -21.01 | -17.25 | -18.74 | -8.31 | -4.32 |
|
Ez-ustiapeneko diru-sarrerak
|
- | - | - | -3.81 | -3.04 | 4.61 | 0.25 | -1.33 | 0.09 | 2.17 | -2.05 | -2.06 | -2.70 | -1.28 | 0.76 |
|
Interesen diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interesen gastuak
|
- | - | - | - | 0.00 | 0.20 | 0.00 | - | - | - | - | - | - | - | - |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
0.02 | -0.55 | -2.06 | -0.28 | -1.58 | 0.61 | -1.43 | 0.02 | 0.01 | -0.07 | -0.10 | 0.02 | 0.00 | -0.16 | -0.03 |
|
Zerga aurreko irabazia
|
- | - | -9.64 | -10.61 | -5.82 | -11.03 | -9.65 | -6.54 | -7.40 | -13.15 | -18.96 | -15.19 | -15.49 | -7.03 | -5.08 |
|
Zerga-gastua
|
- | - | - | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
-22.14 | -7.22 | -9.64 | -10.61 | -5.82 | 11.04 | 9.66 | 6.55 | -7.40 | -13.15 | -18.97 | -15.19 | -16.04 | -7.03 | -5.09 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-8.44 | -5.84 | -7.60 | -14.30 | -8.74 | -6.38 | -9.34 | -7.61 | -7.22 | -10.87 | -20.85 | -17.02 | -18.43 | -7.97 | -3.90 |
|
Akzioko irabazia (oinarrizkoa)
|
-3.80 | -2.53 | -3.96 | -10.10 | -0.15 | -0.31 | -0.48 | 0.03 | -0.48 | -1.40 | -6.82 | -0.31 | -0.42 | -0.24 | 25,773.00 |
|
EPS diluitua
|
- | - | - | - | - | -0.31 | -0.48 | 0.03 | -0.48 | -1.40 | -6.82 | -0.31 | -0.42 | -0.24 | 25,773.00 |
|
Akzioen batez besteko haztatua
|
5.82 | 3.40 | 4.22 | 1.61 | 43.66 | 35.08 | 21.64 | 16.92 | 15.32 | 9.41 | 2.78 | 49.63 | 38.18 | 29.45 | - |
|
Akzioen batez besteko haztatu diluitua
|
- | - | - | - | - | 35.08 | 21.64 | 17.06 | 15.32 | 9.41 | 2.78 | 49.63 | 38.18 | 29.45 | 0.00 |
|
Irabazi globala
|
- | - | - | - | - | - | - | - | - | -13.15 | -18.97 | -15.18 | -16.04 | -7.00 | - |